{"id":124693,"date":"2025-08-06T22:13:15","date_gmt":"2025-08-06T22:13:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/124693\/"},"modified":"2025-08-06T22:13:15","modified_gmt":"2025-08-06T22:13:15","slug":"upling-unveils-ai-powered-cannabis-genetics-tool-to-revolutionize-patient-strain-selection","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/124693\/","title":{"rendered":"Upling Unveils AI-Powered Cannabis Genetics Tool to Revolutionize Patient Strain Selection"},"content":{"rendered":"

[PRESS RELEASE] \u2013 ROCKVILLE, Md., Aug. 6, 2025<\/strong>\u2013 Upling, the leading high-speed medical cannabis delivery app, announced plans to officially launch Bud-E, a groundbreaking AI-powered cannabis genetics tool\u2014an innovative feature designed to help patients identify cannabis strains best suited to their individual health needs.<\/p>\n

\"Advertisment:<\/a>\"Advertisment:<\/a><\/p>\n

Currently in beta testing, Bud-E leverages patient-reported outcomes, medical history, and optional genetic information to generate personalized, science-based strain recommendations using artificial intelligence. A full launch is planned for October.<\/p>\n

\u201cBy combining personal health data, patient feedback, and genetic insights, our platform transforms cannabis from a trial-and-error process into one grounded in science,\u201d said Colin Fraser, founder of Upling, <\/strong>the <\/strong>first Black-owned delivery-focused cannabis app. \u201cWhether someone is managing PTSD, chronic pain, or insomnia, this tool takes the guesswork out and brings a precision medicine approach to cannabis care.\u201d<\/p>\n

\"Advertisment:<\/a>\"Advertisment:<\/a><\/p>\n

With this release, Upling becomes one of the first cannabis delivery platforms to integrate advanced personalization technology directly into the user experience. Bud-E is designed to align with the company\u2019s broader mission: connecting people with the right products, information, and support at every step of their wellness journey.<\/p>\n

\u201cI built Upling after watching my mother struggle to access medication during her cancer treatment,\u201d Fraser said. \u201cImplementing AI to curate cannabis consumption is a natural extension of that mission, removing barriers from the entire process so that patients feel supported from start to finish.\u201d<\/p>\n

\"Advertisment:<\/a><\/p>\n

In recent years, delivery has become a major driver of the legal cannabis industry\u2019s growth. According to the U.S. Department of Health and Human Services, the number of registered medical cannabis patients rose by 37% from 2021 to 2023, fueling the demand for more accessible, patient-centered services. The Centers for Disease Control and Prevention reported that nearly 50% of medical cannabis patients prefer home delivery.<\/p>\n

Bud-E will initially be available to medical cannabis patients in Upling\u2019s Washington, D.C., and Maryland service areas, with plans to expand to adult-use customers in the future.<\/p>\n","protected":false},"excerpt":{"rendered":"[PRESS RELEASE] \u2013 ROCKVILLE, Md., Aug. 6, 2025\u2013 Upling, the leading high-speed medical cannabis delivery app, announced plans…\n","protected":false},"author":3,"featured_media":124694,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[815,159,67,132,68],"class_list":{"0":"post-124693","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114984125030161231","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/124693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=124693"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/124693\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/124694"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=124693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=124693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=124693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}